Drug X which inhibit the binding of RANKL to its receptor (RANK) in osteoporosis:
Ans. C. DenosumabOsteoclasts express RANK receptor which on stimulation causes resorption of bone. Denosumab is monoclonal antibody which inhibit the binding of ligand to the receptor and thus play a role in osteoporosis.
Teriparatide
Alendronate
Denosumab
Estrogen
Endocrinology